Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans

enthalten in: The journal of antimicrobial chemotherapy | May 1, 2016

von Hohmann, N. | Reinhard, R. | Schnaidt, S. | +5

Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans

enthalten in: The journal of antimicrobial chemotherapy | 2016

von Hohmann, N. | Reinhard, R. | Schnaidt, S. | +5

Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans

enthalten in: The journal of antimicrobial chemotherapy | 2016

von Hohmann, N. | Reinhard, R. | Schnaidt, S. | +5

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment

enthalten in: The journal of antimicrobial chemotherapy | 04 August 2014

von Ngaimisi, E. | Burhenne, J.

Steady-state pharmacokinetics and metabolism of voriconazole in patients

enthalten in: The journal of antimicrobial chemotherapy | 2013

von Geist, M. | Egerer, G. | Burhenne, J. | +3

Steady-state pharmacokinetics and metabolism of voriconazole in patients

enthalten in: The journal of antimicrobial chemotherapy | 13 June 2013

von Geist, M. | Egerer, G. | Burhenne, J. | +3

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

enthalten in: The journal of antimicrobial chemotherapy | 2011

von Habtewold, A. | Amogne, W. | Makonnen, E. | +9

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

enthalten in: The journal of antimicrobial chemotherapy | October 2011

von Habtewold, A. | Amogne, W. | Makonnen, E. | +9